CHF Solutions up 26% premarket on use of Aquadex in dialysis patients (NASDAQ:CHFS)

Nano cap CHF Options (NASDAQ:CHFS) jumps 26% premarket on strong quantity in response to its announcement that some COVID-19 dialysis-dependent sufferers who want fluid removing between remedies when dialysis machines or educated personnel are unavailable have been receiving Aquadex remedy, its FDA-approved ultrafiltration system for pediatric and grownup sufferers with treatment-resistant fluid overload.

Lennox Hill Hospital’s Dr. Marian DeVita says, “Acute kidney damage is a major danger for critically in poor health sufferers with COVID-19. Sufficient entry to dialysis gear is a rising concern as is the rising variety of sufferers who want fluid removing however are poor candidates for conventional dialysis. We see ultrafiltration as a useful therapy in each situations and are seeing a transparent profit to together with Aquadex remedy as an important a part of our armamentarium to deal with COVID-19.”